Hui‐Ping Chien

481 citations
18 papers · 368 indexed · h-index 12
Topics
Systemic Lupus Erythematosus Research (3 papers)Renal Diseases and Glomerulopathies (2 papers)Cancer Cells and Metastasis (2 papers)

In The Last Decade

Hui‐Ping Chien

18 papers receiving 362 citations

Peers

Hui‐Ping Chien
Comparison fields: 5 of 59
  • Molecular Biology 152
  • Oncology 141
  • Surgery 83
  • Pulmonary and Respiratory Medicine 76
  • Cancer Research 57
Replace Dai Takeuchi with:
Dai Takeuchi Japan
Chuanming Zheng China
Xueguan Lu China
Kazufumi Sakurama Japan
Elisa Bacillo Italy
Giovanna Vacca Italy
Noelia Vilariño Spain
G. F. W. Scheumann Germany
Adrienne Lawton United States
Hui‐Ping Chien relative to Dai Takeuchi Japan Dai Takeuchi's profile →
Citations per field
00.5×10×15×22×
Dai Takeuchi · 1×
Citations per year

Countries citing papers authored by Hui‐Ping Chien

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ping Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ping Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ping Chien more than expected).

Fields of papers citing papers by Hui‐Ping Chien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ping Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ping Chien. The network helps show where Hui‐Ping Chien may publish in the future.

Co-authorship network of co-authors of Hui‐Ping Chien

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ping Chien. A scholar is included among the top collaborators of Hui‐Ping Chien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ping Chien. Hui‐Ping Chien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 3
2 7
3 11
4 21
5 13
6 14
7 9
8 20
9 3
10 68
11 14
12 27
13 11
14 2
15
Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas.
60
16 16
17 19
18 50

About Hui‐Ping Chien

Hui‐Ping Chien is a scholar working on Transplantation, Oncology and Nephrology, having authored 18 papers that have together received 368 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (3 papers), Renal Diseases and Glomerulopathies (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Oncology (141 citations), Cancer Research (57 citations) and Transplantation (10 citations). Hui‐Ping Chien has collaborated with scholars based in Taiwan, United States and Germany. Frequent co-authors include Chuen Hsueh, Yu‐Sun Chang, Shir‐Hwa Ueng, Shin‐Cheh Chen, Yung‐Chang Lin, Shih‐Che Shen, Liang‐Che Chang, Jim‐Ray Chen, Tsan-Yu Hsieh and Jen‐Der Lin. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026